Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2020-07-21 Purchase | 2020-07-21 7:35 pm | Pandion Therapeutics Inc. | PAND | Kakkar Rahul Chief Executive Officer | 14,000 | $18 | $252,000 | 1,065,256 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2021-04-01 Disposition | 2021-04-01 7:50 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Kakkar Rahul Chief Executive Officer | 570,108 | $0 | 0 (Direct) | View |
2021-04-01 Equity Swap | 2021-04-01 7:50 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Kakkar Rahul Chief Executive Officer | 716,515 | $60 | 0 (Direct) | View |
2021-02-08 Option Award | 2021-02-10 4:47 pm | N/A 2031-02-07 | Pandion Therapeutics Inc. | PAND | Kakkar Rahul Chief Executive Officer | 221,367 | $0 | 221,367 (Direct) | View |
2020-07-17 Option Award | 2020-07-21 7:35 pm | N/A 2030-07-16 | Pandion Therapeutics Inc. | PAND | Kakkar Rahul Chief Executive Officer | 348,741 | $0 | 1,065,256 (Direct) | View |
2020-07-21 Conversion | 2020-07-21 7:35 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Kakkar Rahul Chief Executive Officer | 128,901 | $0 | 1,065,256 (Indirect) | View |
Ownership | 2020-07-16 8:33 pm | N/A N/A | Pandion Therapeutics Inc. | PAND | Kakkar Rahul Chief Executive Officer | 0 | $0 | 702,515 (Indirect) | View |